Warning issued for J&J; drug
From Times Wire Reports
Johnson & Johnson and the Food and Drug Administration warned of reported liver damage and death in patients taking the company’s HIV drug Prezista, according to a letter released Wednesday.
The letter, which J&J; sent to doctors this month, cited cases of drug-induced hepatitis, liver injury and death, though the problems have not been linked directly to Prezista, a protease inhibitor given in combination with Abbott Laboratories’ ritonavir. A J&J; unit said it would put a new warning on the label.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
